MCKENNA MARK C. received a stock award from NEWAMSTERDAM PHARMA CO N.V.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/9/2026ACC: 0001193125-26-009269
Director
Since Jul 2024
+18.70K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
18.70K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+3.40K
Price / share
—
Trade value
—
% of position
48.9%
1/7/2026
6.96K→10.36K
Total
Net shares
+3.40K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 1/7/2026 | A · Award | +3.40K | — | — | 48.9% | 6.96K | 10.36K |
| Total | +3.40K | $0.00 | ||||||
Derivative Transactions1
Option (right to buy)
Direct
Converts to
Ordinary Shares
15.30K shares
Shares
+15.30K
Strike price
35.45
Held after
15.30K
Exercisable
—
1/7/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option (right to buy) Direct | Ordinary Shares15.30K shares | 1/7/2026 | A · Award | +15.30K | 35.45 | — | 15.30K |